Said Knox, “In laboratory testing, HHV-6A is sensitive to acyclovir. So we have a curiosity as well. I mean, that would be pretty dandy, because certainly acyclovir has less toxicity than [AZT], and if you’re talking about treating healthy people in a clinical trial, you’re looking for something that people can take orally.”150 These kinds of findings threatened to derail and discredit Anthony Fauci’s entire HIV/AIDS paradigm. What, after all, would be the implications if a mild, off-patent remedy like acyclovir could safely treat AIDS more effectively than Dr. Fauci’s expensive pharmacopoeia
...more
